Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
LANXESS Aktiengesellschaft: A reportable insider transaction was published on 8th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th October 2024,
The Insider Transaction was made by Müller, Dr. Hans-Joachim 
. The transaction toke place on 4th October 2024. The order was executed at the trading place CBOE EUROPE. . The aggregated volume was 63.951,35 EUR, based on an average price of 29,10 EUR. The nature of the Investment was Buy.
LANXESS Aktiengesellschaft: A reportable insider transaction was published on 8th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th October 2024,
The Insider Transaction was made by Müller, Dr. Hans-Joachim . The transaction toke place on 4th October 2024. The order was executed at the trading place CBOE EUROPE. . The aggregated volume was 2.562,12 EUR, based on an average price of 29,11 EUR. The nature of the Investment was Buy.
LANXESS Aktiengesellschaft: A reportable insider transaction was published on 8th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th October 2024,
The Insider Transaction was made by Müller, Dr. Hans-Joachim . The transaction toke place on 4th October 2024. The order was executed at the trading place TURQUOISE EUROPE. . The aggregated volume was 407,61 EUR, based on an average price of 29,11 EUR. The nature of the Investment was Buy.
LANXESS Aktiengesellschaft: A reportable insider transaction was published on 8th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th October 2024,
The Insider Transaction was made by Müller, Dr. Hans-Joachim . The transaction toke place on 4th October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 18.746,64 EUR, based on an average price of 29,11 EUR. The nature of the Investment was Buy.
LANXESS Aktiengesellschaft: A reportable insider transaction was published on 8th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th October 2024,
The Insider Transaction was made by Müller, Dr. Hans-Joachim . The transaction toke place on 4th October 2024. The order was executed at the trading place CBOE EUROPE. . The aggregated volume was 9.624,86 EUR, based on an average price of 29,08 EUR. The nature of the Investment was Buy.
RWE Aktiengesellschaft: A reportable insider transaction was published on 20th September 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 20th September 2024,
The Insider Transaction was made by Bünting, Dr. Hans Friedrich . The transaction toke place on 19th September 2024. The order was executed at the trading place XETRA. . The aggregated volume was 190.539,59 EUR, based on an average price of 31,92 EUR. The nature of the Investment was Buy.
Fielmann Group AG: A reportable insider transaction was published on 26th August 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th August 2024,
The Insider Transaction was made by Frey, Hans-Georg . The transaction toke place on 23rd August 2024. The order was executed at the trading place Stuttgart. . The aggregated volume was 84.406,40 EUR, based on an average price of 41,60 EUR. The nature of the Investment was Sell.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 21st August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st August 2024,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 21st August 2024. The order was executed at the trading place Gettex. . The aggregated volume was 17.950,00 EUR, based on an average price of 8,97 EUR. The nature of the Investment was Buy.
Aareal Bank AG: A reportable insider transaction was published on 5th March 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 5th March 2024,
The Insider Transaction was made by Lotter, Hans-Hermann Anton . The transaction toke place on 1st March 2024. . The aggregated volume was 400.000,00 EUR, based on an average price of 281.800,00 EUR. The nature of the Investment was Buy.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 15th February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th February 2024,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 15th February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 10.272,66 EUR, based on an average price of 16,33 EUR. The nature of the Investment was Buy.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 14th February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th February 2024,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 14th February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 13.529,00 EUR, based on an average price of 15,84 EUR. The nature of the Investment was Buy.
RWE Aktiengesellschaft: A reportable insider transaction was published on 8th February 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th February 2024,
The Insider Transaction was made by Brandt, Dr. Werner . The transaction toke place on 6th February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 107.839,15 EUR, based on an average price of 32,68 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 28th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 28th December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 14th December 2023. The order was executed at the trading place XETRA. . The aggregated volume was 301.806,31 EUR, based on an average price of 20,12 EUR. The nature of the Investment was Sell.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 23rd October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 162.000,00 EUR, based on an average price of 16,20 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 20th October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 253.488,25 EUR, based on an average price of 16,90 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 13th October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 169.991,69 EUR, based on an average price of 17,00 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 5th October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 174.067,78 EUR, based on an average price of 17,41 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 21st September 2023. The order was executed at the trading place XETRA. . The aggregated volume was 192.700,00 EUR, based on an average price of 19,27 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 21st August 2023. The order was executed at the trading place XETRA. . The aggregated volume was 199.999,04 EUR, based on an average price of 20,00 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 20th July 2023. The order was executed at the trading place XETRA. . The aggregated volume was 263.815,06 EUR, based on an average price of 23,81 EUR. The nature of the Investment was Sell.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.